vs
CAMDEN NATIONAL CORP（CAC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CAMDEN NATIONAL CORP的1.2倍（$75.5M vs $64.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.6%）
卡姆登国民银行是一家总部位于美国缅因州卡姆登的商业银行，是上市银行控股公司卡姆登国民集团的核心子公司。该行创立于1875年，1984年完成企业重组后成为控股公司直接持有的全资子公司。2025年与诺斯韦金融合并后，合并后机构总资产约为70亿美元。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CAC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$64.3M
两年增速更快
PBYI
近两年复合增速
22.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.3M | $75.5M |
| 净利润 | $21.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 34.0% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $1.29 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CACPBYI
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $75.5M | ||
| Q3 25 | $65.4M | $54.5M | ||
| Q2 25 | $62.3M | $52.4M | ||
| Q1 25 | $60.1M | $46.0M | ||
| Q4 24 | $47.6M | $59.1M | ||
| Q3 24 | $45.0M | $80.5M | ||
| Q2 24 | $42.8M | $47.1M |
净利润CACPBYI
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | — | ||
| Q3 25 | $21.2M | $8.8M | ||
| Q2 25 | $14.1M | $5.9M | ||
| Q1 25 | $7.3M | $3.0M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $13.1M | $20.3M | ||
| Q2 24 | $12.0M | $-4.5M |
毛利率CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 22.7% | ||
| Q3 25 | 40.5% | 17.6% | ||
| Q2 25 | 28.5% | 12.7% | ||
| Q1 25 | 10.3% | 8.7% | ||
| Q4 24 | 38.7% | 22.6% | ||
| Q3 24 | 35.2% | 27.4% | ||
| Q2 24 | 34.7% | -4.6% |
净利率CACPBYI
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.4% | 16.2% | ||
| Q2 25 | 22.6% | 11.2% | ||
| Q1 25 | 12.2% | 6.5% | ||
| Q4 24 | 30.8% | — | ||
| Q3 24 | 29.1% | 25.2% | ||
| Q2 24 | 28.0% | -9.6% |
每股收益（稀释后）CACPBYI
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.26 | ||
| Q3 25 | $1.25 | $0.17 | ||
| Q2 25 | $0.83 | $0.12 | ||
| Q1 25 | $0.43 | $0.06 | ||
| Q4 24 | $1.00 | $0.40 | ||
| Q3 24 | $0.90 | $0.41 | ||
| Q2 24 | $0.81 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $514.4M | $22.7M |
| 股东权益账面价值 | $710.0M | $130.3M |
| 总资产 | $7.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.72× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务CACPBYI
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益CACPBYI
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $130.3M | ||
| Q3 25 | $676.4M | $115.3M | ||
| Q2 25 | $652.1M | $104.7M | ||
| Q1 25 | $640.1M | $97.1M | ||
| Q4 24 | $531.2M | $92.1M | ||
| Q3 24 | $529.9M | $71.1M | ||
| Q2 24 | $508.3M | $48.5M |
总资产CACPBYI
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $7.0B | $202.9M | ||
| Q2 25 | $6.9B | $194.9M | ||
| Q1 25 | $7.0B | $196.2M | ||
| Q4 24 | $5.8B | $213.3M | ||
| Q3 24 | $5.7B | $220.7M | ||
| Q2 24 | $5.7B | $205.0M |
负债/权益比CACPBYI
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $14.4M | ||
| Q3 25 | $36.1M | $9.7M | ||
| Q2 25 | $6.0M | $14.1M | ||
| Q1 25 | $1.0M | $3.6M | ||
| Q4 24 | $60.9M | $15.6M | ||
| Q3 24 | $-14.5M | $11.0M | ||
| Q2 24 | $14.5M | $1.0M |
自由现金流CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $14.4M | ||
| Q3 25 | $35.4M | $9.7M | ||
| Q2 25 | $4.5M | $14.1M | ||
| Q1 25 | $-727.0K | $3.6M | ||
| Q4 24 | $55.4M | $15.6M | ||
| Q3 24 | $-16.2M | $11.0M | ||
| Q2 24 | $13.2M | $1.0M |
自由现金流率CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 19.1% | ||
| Q3 25 | 54.1% | 17.7% | ||
| Q2 25 | 7.3% | 26.8% | ||
| Q1 25 | -1.2% | 7.7% | ||
| Q4 24 | 116.4% | 26.4% | ||
| Q3 24 | -36.0% | 13.7% | ||
| Q2 24 | 30.8% | 2.1% |
资本支出强度CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 11.7% | 0.0% | ||
| Q3 24 | 3.8% | 0.0% | ||
| Q2 24 | 3.0% | 0.0% |
现金转化率CACPBYI
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | 1.10× | ||
| Q2 25 | 0.43× | 2.41× | ||
| Q1 25 | 0.14× | 1.21× | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | 0.54× | ||
| Q2 24 | 1.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
PBYI
暂无分部数据
